Animal-based medicines: biological prospection and the sustainable use of zootherapeutic resources

Animals have been used as medicinal resources for the treatment and relieve of a myriad of illnesses and diseases in practically every human culture. Although considered by many as superstition, the pertinence of traditional medicine based on animals cannot be denied since they have been methodically tested by pharmaceutical companies as sources of drugs to the modern medical science. The phenomenon of zootherapy represents a strong evidence of the medicinal use of animal resources. Indeed, drug companies and agribusiness firms have been evaluating animals for decades without paying anything to the countries from where these genetic resources are found. The use of animals' body parts as folk medicines is relevant because it implies additional pressure over critical wild populations. It is argued that many animal species have been overexploited as sources of medicines for the traditional trade. Additionally, animal populations have become depleted or endangered as a result of their use as experimental subjects or animal models. Research on zootherapy should be compatible with the welfare of the medicinal animals, and the use of their by-products should be done in a sustainable way. It is discussed that sustainability is now required as the guiding principle for biological conservation.<br>Os animais são utilizados como recursos medicinais para o tratamento e alívio de um gama de doenças e enfermidades em praticamente toda cultura humana. A pertinência da medicina tradicional baseada em animais, embora considerada como superstição, não deve ser negada uma vez que os animais têm sido testados metodicamente pelas companhias farmacêuticas como fontes de drogas para a ciência médica moderna. O fenômeno da zooterapia representa uma forte evidência do uso medicinal de recursos animais. De fato, as indústrias farmacêuticas e de agronegócios há décadas vêm avaliando animais sem pagar tributos aos países detentores desses recursos genéticos. A utilização de partes do corpo dos animais como remédios tradicionais é relevante porque implica pressão adicional sobre populações selvagens críticas. Discute-se que muitas espécies animais estão sendo exploradas em excesso como fontes de medicamentos para o comércio tradicional. Além disso, as populações animais ficaram exauridas ou ameaçadas como resultado do uso como objetos de experimentação ou modelos animais. A pesquisa sobre zooterapia deveria ser compatível com o bem-estar dos animais, assim como o uso dos produtos medicinais deveria ser guiado de modo sustentável. Sabe-se que a sustentabilidade deve ser tida como um princípio orientador para a conservação biológica

Quinones and halogenated monoterpenes of algal origin show anti-proliferative effects against breast cancer cells in vitro

Red and brown algae have been shown to produce a variety of compounds with chemotherapeutic potential. A recent report described the isolation of a range of novel polyhalogenated monoterpene compounds from the red algae Plocamium corallorhiza and Plocamium cornutum collected off the coast of South Africa, together with the previously described tetraprenylquinone, sargaquinoic acid (SQA), from the brown algae Sargassum heterophyllum. In our study, the algal compounds were screened for anti-proliferative activity against metastatic MDA-MB-231 breast cancer cells revealing that a number of compounds displayed anti-cancer activity with IC50 values in the micromolar range. A subset of the compounds was tested for differential toxicity in the MCF-7/MCF12A system and five of these, including sargaquinoic acid, were found to be at least three times more toxic to the breast cancer than the non-malignant cell line. SQA was further analysed in terms of its mechanism of cytotoxicity in MDA-MB-231 cells. The ability to initiate apoptosis was distinguished from the induction of an inflammatory necrotic response via flow cytometry with propidium iodide and Hoescht staining, confocal microscopy with Annexin V and propidium iodide staining as well as the PARP cleavage assay. We report that SQA induced apoptosis while a polyhalogenated monoterpene RU015 induced necrosis in metastatic breast cancer cells in vitro. Furthermore, we demonstrated that apoptosis induction by SQA occurs via caspase-3, -6, -8, -9 and -13 and was associated with down-regulation of Bcl-2. In addition, cell cycle analyses revealed that the compound causes G1 arrest in MDA-MB-231 cells